Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial

Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: a randomized, double-blind, placebo-controlled trial

<p>Abstract</p> <p>Background</p> <p>Increasing evidence suggests the bidirectional interplay between parathyroid hormone and aldosterone as an important mechanism behind the increased risk of cardiovascular damage and bone disease observed in primary hyperparathyroidis...

Full description

Bibliographic Details
Main Authors: Tomaschitz Andreas, Fahrleitner-Pammer Astrid, Pieske Burkert, Verheyen Nicolas, Amrein Karin, Ritz Eberhard, Kienreich Katharina, Horina Jörg H, Schmidt Albrecht, Kraigher-Krainer Elisabeth, Colantonio Caterina, Meinitzer Andreas, Pilz Stefan
Format: Article
Language:English
Published: BMC 2012-09-01
Series:BMC Endocrine Disorders
Subjects:
Aldosterone
Mineralocorticoid receptor blocker
Hyperparathyroidism
Online Access:http://www.biomedcentral.com/1472-6823/12/19

Internet

http://www.biomedcentral.com/1472-6823/12/19

Similar Items